PortfoliosLab logoPortfoliosLab logo
CANC vs. UUP
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

CANC vs. UUP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tema Oncology ETF (CANC) and Invesco DB US Dollar Index Bullish Fund (UUP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CANC achieves a 17.91% return, which is significantly higher than UUP's 5.44% return.


CANC

1D
-1.73%
1M
9.22%
6M
13.62%
YTD
17.91%
1Y
58.70%
3Y*
104.11%
5Y*
10Y*

UUP

1D
0.39%
1M
1.97%
6M
4.47%
YTD
5.44%
1Y
8.28%
3Y*
5.86%
5Y*
5.89%
10Y*
3.17%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CANC vs. UUP - Yearly Performance Comparison


2026 (YTD)20252024202320222021
CANC
Tema Oncology ETF
17.91%42.92%-5.37%510.51%-85.34%-55.35%
UUP
Invesco DB US Dollar Index Bullish Fund
5.44%-4.99%13.50%3.63%9.46%1.10%

Correlation

The correlation between CANC and UUP is -0.30, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.30

Correlation (3Y)
Calculated over the trailing 3-year period

-0.27

Correlation (All Time)
Calculated using the full available price history since Sep 30, 2021

-0.21

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CANC vs. UUP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CANC
CANC Risk / Return Rank: 9292
Overall Rank
CANC Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
CANC Sortino Ratio Rank: 9292
Sortino Ratio Rank
CANC Omega Ratio Rank: 8686
Omega Ratio Rank
CANC Calmar Ratio Rank: 9595
Calmar Ratio Rank
CANC Martin Ratio Rank: 9292
Martin Ratio Rank

UUP
UUP Risk / Return Rank: 5151
Overall Rank
UUP Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
UUP Sortino Ratio Rank: 5050
Sortino Ratio Rank
UUP Omega Ratio Rank: 4949
Omega Ratio Rank
UUP Calmar Ratio Rank: 5757
Calmar Ratio Rank
UUP Martin Ratio Rank: 4747
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CANC vs. UUP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tema Oncology ETF (CANC) and Invesco DB US Dollar Index Bullish Fund (UUP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CANCUUPDifference
Sharpe ratioReturn per unit of total volatility

+1.21

Sortino ratioReturn per unit of downside risk

+1.63

Omega ratioGain probability vs. loss probability

1.41

1.25

+0.16

Calmar ratioReturn relative to maximum drawdown

6.34

2.28

+4.06

Martin ratioReturn relative to average drawdown

17.26

6.26

+11.00

CANC vs. UUP - Sharpe Ratio Comparison

The current CANC Sharpe Ratio is 2.60, which is higher than the UUP Sharpe Ratio of 1.38. The chart below compares the historical Sharpe Ratios of CANC and UUP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CANC vs. UUP - Drawdown Comparison

The maximum CANC drawdown since its inception was -97.53%, which is greater than UUP's maximum drawdown of -22.19%. Use the drawdown chart below to compare losses from any high point for CANC and UUP.


Loading charts...

Drawdown Indicators


CANCUUPDifference

Max Drawdown

Largest peak-to-trough decline

-97.53%

-22.19%

-75.34%

Max Drawdown (1Y)

Largest decline over 1 year

-9.30%

-3.65%

-5.65%

Max Drawdown (3Y)

Largest decline over 3 years

-30.27%

-10.05%

-20.22%

Max Drawdown (5Y)

Largest decline over 5 years

-10.37%

Max Drawdown (10Y)

Largest decline over 10 years

-14.24%

Current Drawdown

Current decline from peak

-51.12%

-1.26%

-49.86%

Average Drawdown

Average peak-to-trough decline

-72.70%

-8.88%

-63.82%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.41%

1.33%

+2.08%

Volatility

CANC vs. UUP - Volatility Comparison

Tema Oncology ETF (CANC) has a higher volatility of 6.48% compared to Invesco DB US Dollar Index Bullish Fund (UUP) at 1.45%. This indicates that CANC's price experiences larger fluctuations and is considered to be riskier than UUP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CANCUUPDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.48%

1.45%

+5.03%

Volatility (6M)

Calculated over the trailing 6-month period

16.50%

4.34%

+12.16%

Volatility (1Y)

Calculated over the trailing 1-year period

22.78%

6.03%

+16.75%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

277.14%

7.22%

+269.92%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

277.14%

6.90%

+270.24%

CANC vs. UUP - Expense Ratio Comparison

Both CANC and UUP have an expense ratio of 0.75%.


Dividends

CANC vs. UUP - Dividend Comparison

CANC's dividend yield for the trailing twelve months is around 0.05%, less than UUP's 3.25% yield.


PositionTTM202520242023202220212020201920182017
CANC
Tema Oncology ETF
0.05%0.06%3.00%0.56%0.00%0.00%0.00%0.00%0.00%0.00%
UUP
Invesco DB US Dollar Index Bullish Fund
3.25%3.43%4.48%6.44%0.89%0.00%0.00%2.03%1.08%0.10%

Frequently Asked Questions


CANC and UUP have a correlation of -0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CANC has higher volatility (6.48%) compared to UUP (1.45%). In terms of maximum drawdown, CANC dropped -97.53% vs UUP's -22.19%.

On 3-year performance, CANC leads with 104.11% vs 5.86% for UUP. Both ETFs have the same 0.75% expense ratio. On volatility, UUP has been the lower-risk option at 1.45%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 3-year period, CANC has performed better with a 104.11% return vs 5.86%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

CANC and UUP have the same expense ratio: 0.75% per year.

UUP has the higher dividend yield at 3.25%, compared with 0.05% for CANC.

CANC is categorized as Health & Biotech Equities, while UUP is Currency. They also come from different issuers: Tema and Invesco.

CANC currently has the higher Sharpe Ratio (2.60 vs 1.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CANC and UUP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer